RELATED ATTORNEYS
Carlson Caspers successfully represented Barr in a Hatch-Waxman patent infringement dispute over its effort to market a generic version of Focalin® tablets (dexmethylphenidate). Our client was able to achieve a favorable settlement as a result of our effective challenge of the validity of the asserted patents.